21 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
6-K
EX-1.1
aegq14pacetl9eo9lgeg
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-99.1
47awu
3 Feb 21
Current Report
7:55am
6-K
EX-99.1
mvt1unz
3 Dec 20
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:00am
6-K
EX-99.1
vrfxhedv
27 Oct 20
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
5blbgi7miy3ha4
22 Oct 20
Enlivex Reports Dosing of First Two Patients in Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:49am
6-K
EX-10.1
zasl8
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
suczgy04pj
13 Oct 20
Report of Foreign Private Issuer
9:30am
6-K
EX-99.1
luveihk w3
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
xs00aw3
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
7lmwr97958l biev
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-99.2
60xk045 a19
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm